Group | SOD | CAT | GSH-Px | GSH |
(U/mg) | (U/ml) | (U/mg) | (ng/ml) | |
Control group | 24.81 ± 2.72 | 68.66 ± 6.50 | 403.66 ± 92.83 | 3.56 ± 0.76 |
Low-dose group | 25.79 ± 4.62 | 53.37 ± 8.89* | 290.37 ± 57.71* | 2.69 ± 0.90 |
Middle-dose group | 19.59 ± 3.16* | 36.48 ± 3.79* | 346.79 ± 41.75* | 3.41 ± 1.29 |
High-dose group | 19.48 ± 1.91* | 42.97 ± 6.11* | 243.18 ± 42.89* | 4.26 ± 1.29 |
Group | MDA | T-AOC | NOS | SOD/MDA |
(nmol/mg) | (U/ml) | |||
Control group | 0.48 ± 0.06 | 0.74 ± 0.12 | 0.49 ± 0.17 | 55.91 ± 8.42 |
Low-dose group | 0.66 ± 0.13* | 0.44 ± 0.02* | 0.74 ± 0.19* | 42.62 ± 10.17* |
Middle-dose group | 0.31 ± 0.05* | 0.44 ± 0.09* | 0.54 ± 0.14 | 70.71 ± 20.10* |
High-dose group | 0.40 ± 0.07* | 0.37 ± 0.08* | 0.61 ± 0.10 | 51.96 ± 12.08 |